Lyme borreliosis vaccination: The facts, the challenge, the future

84Citations
Citations of this article
144Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Lyme disease, or Lyme borreliosis, the most prevalent arthropod-borne disease in the Western world, is caused by spirochetes belonging to the Borrelia burgdorferi sensu lato group and is predominantly transmitted through Ixodes ticks. There is currently no vaccine available to prevent Lyme borreliosis in humans. Borrelia outer membrane proteins are reviewed which have been investigated as vaccine candidates. In addition, several tick proteins are discussed, on which anti-tick vaccines have been based, or are interesting future candidates, to prevent transmission of the spirochete from the tick vector to the mammalian host. Finally, novel vaccination strategies to prevent Lyme borreliosis are proposed, based on multiple Borrelia antigens, tick antigens or a combination of both Borrelia as well as tick antigens. © 2010 Elsevier Ltd.

Cite

CITATION STYLE

APA

Schuijt, T. J., Hovius, J. W., van der Poll, T., van Dam, A. P., & Fikrig, E. (2011, January). Lyme borreliosis vaccination: The facts, the challenge, the future. Trends in Parasitology. https://doi.org/10.1016/j.pt.2010.06.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free